老年2型糖尿病住院病人共病情况分析

doi:10.3969/j.issn.1003-9198.2021.11.016

摘要/Abstract

摘要： 目的了解老年T2DM住院病人的共病情况。方法采用回顾性研究方法,收集我科住院的427例老年T2DM病人的临床资料,计算Charlson共病指数(CCI),并根据CCI得分分为低共病组(≤2分)和高共病组(>2分)。分析2组病人的一般情况、伴发疾病、血糖控制和多重用药情况。结果 427例老年T2DM病人中,高共病患病率(CCI＞2分)为65.34%(279/427)。高共病组的年龄和糖尿病病程显著大于低共病组,差异有统计学意义(P＜0.05)。高共病组中有88.53%伴发高血压、81.00%伴发高血脂、63.44%伴发外周动脉血管疾病、60.93%伴发脑血管病、40.50%伴发缺血性心脏病,低共病组中有77.70%伴发高血脂、62.84%伴发外周动脉血管疾病、53.38%伴发高血压。高共病组伴多重用药的比例(62.37%)显著高于低共病组(47.30%),差异有统计学意义(P＜0.01)。低共病组和高共病组血糖控制及胰岛功能比较,差异没有统计学意义(P＞0.05)。结论老年T2DM高共病病人较低共病病人年龄大、病程长、多重用药比例高,更容易伴发高血压和心脑血管疾病。

关键词: 2型糖尿病, 老年人, 共病, 多重用药

Abstract: Objective To investigate the comorbidities in the elderly patients with type 2 diabetes mellitus (T2DM). Methods A retrospective study was conducted to collect clinical data of 427 hospitalized elderly patients with T2DM. The Charlson comorbidity index (CCI) was calculated. CCI≤2 was defined as low comorbidity group, and CCI > 2 was defined as high comorbidity group. The general condition, comorbidites, blood glucose control and multiple drug use were analyzed in different comorbidity group. Results Among 427 elderly patients with T2DM, the high comorbidities prevalence was 65.34%. The age and course of diabetes of the high comorbidity group were significantly higher than those of the low comorbidity group (P<0.05).In the high comorbidity group, 88.53% were complicated with hypertension, 81.00% with hyperlipidemia, 63.44% with peripheral artery disease, 60.93% with cerebrovascular disease, and 40.50% with ischemic heart disease. In the low comorbidity group, 77.70% were complicated with hyperlipidemia, 62.84% with peripheral artery disease, and 53.38% with hypertension. The proportion of polypharmacy in high comorbidity group (62.37%) was significantly higher than that of low comorbidity group (47.30%) (P<0.01). There were no significant differences in blood glucose control and islet function between low comorbidity group and high comorbidity group (P>0.05). Conclusions Compared with the low comorbidity group, the patients in the high comorbidity group show older age, longer course of disease, higher proportion of taking multiple drugs, and are more likely to be complicated with diseases such as hypertension, cardiovascular and cerebrovascular diseases.

Key words: type 2 diabetes mellitus, aged, comorbidity, polypharmacy

中图分类号:

R 587.1

纪倩云, 李曼, 崔雯霞, 高蕾, 潘丰慧, 张铭瑞, 胡云. 老年2型糖尿病住院病人共病情况分析[J]. 实用老年医学, 2021, 35(11): 1170-1173.

JI Qian-yun, LI Man, CUI Wen-xia, GAO Lei, PAN Feng-hui, ZHANG Ming-rui, HU Yun. Analysis of comorbidities in elderly inpatients with type 2 diabetes mellitus[J]. Practical Geriatrics, 2021, 35(11): 1170-1173.

参考文献

[1] SAEEDI P, PETERSOHN I, SALPEA P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition[J]. Diabetes Res Clin Pract, 2019,157:107843.
[2] 闫伟,路云,张冉,等.基于CHARLS数据分析的我国老年人共病现状研究[J]. 中华疾病控制杂志,2019,23(4):426-430.
[3] CHARLSON M E, CHARLSON R E, PETERSON J C, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients[J]. J Clin Epidemiol, 2008, 61(12):1234-1240.
[4] MATTHEWS D R, HOSKER J P, RUDENSKI A S, et al. Homeostasis model assessment:insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia,1985,28(7):412-419
[5] 中华医学会老年医学分会,陈旭娇,严静,等.老年综合评估技术应用中国专家共识[J]. 中华老年医学杂志,2017,36(5):471-477.
[6] 中华医学会糖尿病分会.中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志,2018,10(1):4-67.
[7] XU Y, WANG L, HE J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA,2013,310(9):948-959.[8] 徐兰,王梦婧,陈靖.老年共病与肾功能损伤[J]. 中华老年医学杂志,2020,39(4):377-379.
[9] 管丽娟,邓明洪,王凌霄,等.住院老年共病患者的慢性疾病和老年综合征分析[J]. 中华老年医学杂志,2019,38(2):176-180.
[10] WOLFF J L,STARFIELD B,ANDERSON G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly[J]. Arch Intern Med, 2002, 162(20): 2269-2276.
[11] UIJEN A A,VAN DE LISDONK E H. Multimorbidity in primary care: prevalence and trend over the last 20 years[J]. Eur J Gen Pract, 2008,14(suppl 1): 28-32.
[12] BRITT H C,HARRISON C M,MILLER G C, et al. Prevalence and patterns of multimorbidity in Australia[J]. Med J Aust, 2008, 189(2):72-77.
[13] FORTIN M,HUDON C,HAGGERTY J, et al. Prevalence estimates of multimorbidity: a comparative study of two sources[J]. BMC Health Serv Res,2010,10(1):111-116.
[14] 王姣锋,张紫欢,崔月,等.上海部分社区老年人共病患病模式及其影响因素分析[J]. 老年医学与保健,2017,23(2):97-101.
[15] 殷立新,张立辉.特殊人群用药指导丛书:老年人用药指导[M].北京:人民卫生出版社,2012.
[16] JI L N, HU D Y,PAN C Y, et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients[J]. Am J Med, 2013, 126(10): 925.e11-22.
[17] HYLAND K A, GREINER M A, QUALLS L G, et al. Trends in the care and outcomes of medicare beneficiaries with type 2 diabetes,2002-2011[J]. Endocr Pract, 2016, 22(8): 920-934.